Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652093 · ClinicalTrials.gov registry record · Phase 4
Lumbar Stenosis Outcomes Research II
A Phase 4 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00652093 is a Phase 4 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 24 participants.
The verdict
NCT00652093, a Phase 4 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The primary objective of the proposed pilot study is to determine the efficacy of oxymorphone hydrochloride and propoxyphene/acetaminophen combination in prolonging the time to onset of pain and reducing the severity of pain associated with walking in patients lumbar spinal stenosis that have clinical symptoms of neurogenic claudication. Neurogenic claudication is defined as movement induced leg pain, numbness, heaviness, or vague discomfort in part or all of one or both legs provoked with walking and standing and relieved by sitting, squatting, or forward flexion posturing. The secondary objective is to examine the functional benefit of oxymorphone hydrochloride and propoxyphene/acetaminophen combination with respect to improvement in duration and distance of walking.
Interventions
- DRUG opana then darvocet then placebo
- DRUG opana then placebo then darvocet
- DRUG placebo then opana then darvocet
- DRUG Placebo then darvocet then opana
- DRUG Darvocet then opana then placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00652093
The ClinicalTrials.gov registry entry for NCT00652093 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which opana then darvocet then placebo is the first listed.
NCT00652093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00652093 about?
NCT00652093 is a clinical study titled "Lumbar Stenosis Outcomes Research II". The primary objective of the proposed pilot study is to determine the efficacy of oxymorphone hydrochloride and propoxyphene/acetaminophen combination in prolonging the time to onset of pain and reducing the severity of pain associated with walking in patients lumbar spinal stenosis that have clinic...
What is the current status of trial NCT00652093?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2008-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00652093?
The interventions under investigation include: opana then darvocet then placebo (DRUG), opana then placebo then darvocet (DRUG), placebo then opana then darvocet (DRUG), Placebo then darvocet then opana (DRUG), Darvocet then opana then placebo (DRUG).
Who is sponsoring clinical trial NCT00652093?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.